en

PRODUCT DETAIL

ZOSTAVAX prášok a disperzné prostredie na injekčnú suspenziu v naplnenej injekčnej striekačke

Code 36412
MA number EU/1/06/341/013
Product Form: plv iul 20x >19 400 PFU +20x solv. (skl.liek.+napl.skl.striek.s 2 samost.ihlami)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Merck Sharp & Dohme B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BK Varicella zoster vaccines
J07BK02 Zoster, live attenuated
Shelf life: 18
Container: glass container
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application
MA issued: 19.05.2006
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 20.06.2018
eu-flag.png sk-flag.png